MENDRISIO, Switzerland and PRINCETON, N.J, March 27, 2023 /PRNewswire/ -- Sintetica S.A., an international pharmaceutical company with manufacturing facilities in Switzerland, announces the launch of Lidocaine Hydrochloride Injection, USP 1%, 2% and 4% through its subsidiary Sintetica US.
At the time, Norgine said its split with the Association was because the group no longer represented the interests of smaller, specialist firms, and that its agenda was driven by the interests of its largest multinational members.
Sintetica`s Generic Baclofen approved in US as muscle relaxer, antispastic agent
Market Place
Share
SINTETICA SA News Full Screen View
Share
